Susquehanna International Group’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,200
Closed -$230K 10966
2016
Q4
$230K Buy
+8,200
New +$230K ﹤0.01% 8450
2015
Q3
Sell
-13,300
Closed -$330K 11038
2015
Q2
$330K Sell
13,300
-4,600
-26% -$114K ﹤0.01% 8377
2015
Q1
$451K Buy
17,900
+4,600
+35% +$116K ﹤0.01% 7281
2014
Q4
$312K Sell
13,300
-11,500
-46% -$270K ﹤0.01% 8066
2014
Q3
$565K Sell
24,800
-5,000
-17% -$114K ﹤0.01% 6983
2014
Q2
$729K Buy
29,800
+20,100
+207% +$492K ﹤0.01% 6716
2014
Q1
$205K Buy
+9,700
New +$205K ﹤0.01% 8196
2013
Q4
Sell
-13,900
Closed -$297K 9856
2013
Q3
$297K Sell
13,900
-13,600
-49% -$291K ﹤0.01% 7224
2013
Q2
$548K Buy
+27,500
New +$548K ﹤0.01% 5906

Other funds holding QGENF

Susquehanna International Group's QGENF Position: Q1 2017 in Review

Susquehanna International Group sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 47,086 shares — an estimated $1.32M sold.

Susquehanna International Group first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $5.26M in Q2 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Susquehanna International Group reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Susquehanna International Group sold 47,086 QIAGEN NV shares in Q1 2017, an estimated $1.32M.
  • Susquehanna International Group first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • Susquehanna International Group's QIAGEN NV position peaked at $5.26M in Q2 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.